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 Objective: To report a Central Nervous System 
infection evolving with brain abscess and to address aspects 
of the treatment of the disease. Results: even with 
advances in treatment and diagnosis, the pathology has a 
high mortality. However, the best prognosis is noticed when 
there is a suspicion through the clinic, neuroradiological 
images readily available, antimicrobial therapy against 
commonly encountered agents, and surgical drainage 
procedures. One study, which combined antibiotic therapy 
and surgery to drain the abscess, in most of the cases, 
studied, demonstrated a mortality rate of 12%, and another 
study, a 42% mortality rate when using antibiotic therapy 
alone. Another reference suggests the use of antibiotic 
therapy alone in less severe cases with less neurological 
impairment. Neurological clinical sequelae can be found in 
up to 30% of cases. The time of antibiotic therapy still 
needs to be debated, as well as the surgical indication for 
drainage. Final Considerations: Pediatric brain abscess is 
an uncommon disease, still with high morbidity and 
mortality. Surgical drainage or excision of pediatric 
abscesses remains the basis of treatment both to relieve 
the mass effect and to provide a microbiological diagnosis. 
The literature demonstrates that broad-spectrum 
antibiotics and access to CT and MRI images decrease the 
rates of morbidity and mortality. It is concluded that the 
therapeutic approach involves the administration of broad 
spectrum intravenous antibiotics and surgical drainage in 
more complex cases. 
 




A cerebral abscess (CA) is an infection in the 
cerebral parenchyma that can arise as a complication of a 
variety of pathological conditions such as surgery, trauma, 
and as a result of other primary infections [1]. Most of the 
time, the clinical symptoms of brain abscess are related to 
intracranial hypertension (ICH), which is generally 
associated with secondary brain conditions in children, 
resulting in high morbidity and mortality, varying between 
13% to 20% [2]. Brain abscesses are serious conditions, 
uncommon in the pediatric population, but of great clinical 
importance due to significant long-term mortality, 
demonstrating a prevalence of 0.4% to 0.9% for every 
1000 people on a global scale [3]. 
The pathogenesis of cerebral abscess is explained 
through two main pathways: contiguity or hematogenic. 
Infections such as otitis media, mastoiditis, sinusitis, 
dental infections, trauma, and surgery correspond to the 
primary sites of contiguous infection. The conditions 
disseminated by the hematogenous route are more 
associated with pulmonary, intra-abdominal, pelvic, skin 
infections,  
and congenital cyanotic heart disease, being, therefore, 
little described as secondary to neonatal infections [4,5]. 
The microorganisms found are usually gram-
positive bacteria, such as Streptococcus viridian's, 
Staphylococcus aureus, and also gram negative bacteria, 
related to ear infections and head injuries, such as 
Klebsiella pneumonia, E. coli, Proteus, and Pseudomonas 
spp [6]. In newborns, the main agents are those related 
to early neonatal sepsis, being Streptococcus agalactiae 
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Symptoms are related to increased intracranial 
pressure with episodes of vomiting, nausea, headaches, 
chronic repercussions in the central nervous system (50 to 
80%), followed by poor mental development, epilepsy, and 
behavior-related disorders [7,8]. In newborns, the clinical 
manifestations may be nonspecific as occurs in neonatal 
septic infections, corresponding to diet intolerance, 
vomiting, cyanosis, apneas or respiratory changes 
(respiratory distress), hypoactivity, seizures, among other 
symptoms. 
In the clinical suspicion of brain abscess, computed 
tomography (CT) is requested. The worsening or sudden 
death of the patient may indicate a rupture of the abscess, 
a critical complication that leads to high mortality due to 
the sudden increase in intracranial pressure and intense 
toxemia caused by the release of purulent content within 
the ventricles or parenchyma. The treatment indicated is 
broad-spectrum antibiotics, with good penetration into the 
central nervous system and reaching aerobic and 
anaerobic, the duration varies from 6 to 8 weeks, with 
follow-up by serial CT. Neurosurgery is indicated if there is 
no improvement, allowing drainage with relief from 
intracranial hypertension and obtaining material for study 
[8]. 
Therefore, this study reported a clinical case that 
occurred in an infant who had a Central Nervous System 
infection evolving with brain abscess, and due to its 
severity, morbidity, and unusual evolution in the pediatric 
population, we aim to address the time of infection and 
aspects of the treatment of disease. 
 
 Methods 
 Study Design – Case Report 
 The present study was elaborated according to the 
rules of CARE case report (https://www.care-
statement.org/) [9]. The present study is a case report 
whose bibliographic research used the descriptors: cerebral 
abscess and intracranial hypertension. The research was 
carried out through the study of digital articles and virtual 
books attached to the Google academic, in database 
platforms such as Scientific Electronic Library Online 
(SCIELO), PubMed, and in scientific repositories, according 
to PRISMA (Systematic Review). Used as the main data 
sources, the most relevant works were selected for the 
theme for the synthesis and presentation of the 
information, excluding references that diverged from the 
purposes covered here. 
 
 Patient Information and Clinical Findings, Timeline, 
Diagnostic, Assessment, Therapeutic, Intervention/  
 
Follow-up and Informed Consent 
E.M.C, 1 month and 25 days, female, born and 
living in the city of Marilia, state of Sao Paulo. She was 
referred to the pediatric service of Santa Casa de 
Misericordia de Marilia, with a history of fever, crying, 
irritability for 1 day, with no respiratory and intestinal 
symptoms, associated with a bulging fontanelle, 
nystagmus, and looking in the setting sun. There was no 
previous trauma. She was admitted to the Emergency 
Room on 10/18/2019 and performed a cerebrospinal fluid 
(CSF) puncture, and after the procedure, the patient had 
a skin motive (livedo reticularis) and groaning, and was 
referred to the ICU.  
A cranial tomography was performed, showing an 
extra right axial frontal cystic lesion with a midline 
deviation, greater than 30 mL of content and with 
apparent skull base origin, followed by a percutaneous 
puncture via the right coronal suture with an outlet of 
greenish purulent secretion with a foul odor. Antibiotic 
therapy was initiated with Ceftriaxone 100mg/kg/day 
(12/12 hrs), Metronidazole 10mg/kg/day (8/8 hrs) and 
Oxacillin 50mg/kg/day (6/6 hrs). The next day, the infant 
remained feverish where bacterial culture was carried out 
and multi-sensitive E. coli (sensitive to ceftriaxone) was 
identified in the CSF and brain abscess. On 10/20 the 
fever ceased and the antibiotics Metronidazole and 
Oxacillin were suspended, with only Ceftriaxone 
remaining.  
She evolved with a seizure crisis, controlled after 
an attack dose of Phenobarbital, and another feverish 
peak occurred again. On 10/22, despite being 
asymptomatic, she performed a video-
electroencephalogram (video-EEG) that found the 
presence of mild disorganization and discharges in the left 
frontal lobe. On the fifth day of hospitalization, there was 
an improvement in the infectious score (Rodwell's 
hematological score), but with sodium hydro electrolytic 
disorder (hyponatremia).  
On 10/24, drowsy, fasting, presented a new 
seizure episode, being medicated and repeated cranial 
tomography that maintained an earlier pattern. The 
second puncture was performed via a coronal suture, with 
drainage of 100 mL of pus, the culture result of which 
remained with the growth of E. coli multi-S. On 10/25, the 
patient presented a good evolution with a resolution of 
hyponatremia. Keeping without new seizures, and the 
serum level of intravenous phenytoin anticonvulsant at 
8.6 ug/mL, it was programmed to replace it with oral 
Oxycarbamazepine. She was discharged from the 
pediatric ICU and was transferred to an infirmary bed. 
On 11/08 the patient was readmitted to the ICU 
due to a new seizure after the removal of the intravenous 
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anticonvulsant, she presented episodes of nystagmus and 
convulsive movements of the upper limbs. A new CT 
(09/11) was performed, showing a reduction in abscess, 
but with progression to communicating hydrocephalus and 
areas of gliosis, with no surgical indication at this time. The 
IV anticonvulsants were maintained and without new 
seizures. On 11/11, it evolved with a bulging fontanelle, a 
new CT scan was performed that showed the same pattern 
as before and maintained without surgical indication. An 
echocardiogram was also performed due to the presence of 
a heart murmur, which revealed the presence of a patent 
foramen ovale and the absence of vegetation in heart 
valves. The evolutionary control of the video-EEG (11/11) 
showed the presence of disorganization in brain waves, 
however reactive, with nonspecific delta outbreaks (which 
may correspond to discognitive crises or intracranial 
hypertension).  
The levels of anticonvulsants were therapeutic and 
a Transfontanellar Ultrasound was performed, which 
maintained the same pattern as the last cranial CT scan 
(with no signs of intracranial hypertension). On 11/23, 
presenting hypoactivity and worsening of the general 
condition. A new skull CT scan was performed, which 
showed a decrease in abscess, but important 
hydrocephalus with signs of CSF transudation into the 
parenchyma. Vancomycin started 15 mg/ kg/dose, EV, 6/6 
hours and Cefepime 50 mg/kg/dose, EV, 8/8 hours. On 
11/24 there was an improvement in hypoactivity. After 2 
days, on 11/26, she was sucking her breast, followed by IV 
anticonvulsants. On 11/27, the result of the LCR culture was 
negative. On 11/29, a new CT scan was performed, which 
showed an increase in hydrocephalus, an abscess similar to 
the previous one with 3 cm in the right frontal lobe, erasure 
of furrows, and CSF transudation. 
On 11/30/2019, the patient received the vaccines 
for 2 months, except rotavirus. It was suggested by the 
Hospital Infection Control Commission to maintain the 
antibiotic for 56 days of treatment, which would complete 
8 weeks of treatment and later programmed DVP 
(peritoneal ventricle shunt). She presented weight gain and 
good acceptance of breast milk. One day after the 
aforementioned date, the serum level of anticonvulsants 
(phenytoin and phenobarbital) was collected, and after 
that, the drugs were switched to oral. 
On 12/03/2019, a 30 mL CSF puncture was 
performed, as there was an increase in head circumference, 
followed by bacterial culture. On 12/05/2019 the result of 
the culture obtained was negative, and Vancomycin was 
suspended and de-escalated Cefepime for Ceftriaxone, 
remaining stable. On December 6, 2019, transferred to 
home-care to finish treatment. She continued to follow up 
with motor physiotherapy, occupational therapy, and 
nutrition. On December 21, 2019, she was readmitted to  
perform the left peritoneal ventricle shunt due to 
hydrocephalus, which occurred without abnormalities. 
 Informed Consent 




A cerebral abscess occurs when there is an 
infection that affects the cerebral parenchyma, which is 
usually focal [10]. The main predisposing conditions in 
children are the adjacent focus of infection, trauma, 
hematogenous dissemination, neurosurgical procedures, 
cyanotic heart disease, and immunosuppression [11]. 
The pathology is rare in adult patients and with 
an even lower incidence in the pediatric age group. With 
the development of medicine, it has become rare with an 
incidence of 0.3-1.8 per 100,000 inhabitants per year. In 
general, about 25% occur in children and more often 
between 4 and 10 years of age [3,5,7]. Even with 
advances in treatment and diagnosis, the pathology has 
effective mortality [10]. However, the best prognosis is 
noticed when there is a suspicion through the clinic, 
neuroradiological images readily available, antimicrobial 
therapy against commonly found agents, and surgical 
drainage procedures [12]. 
Infectious pathogens vary depending on the 
infection etiology, location, age, and underlying medical 
condition [13]. Pediatric cultures positive for 
Streptococcus spp., Staphylococcus spp. and gram-
negative enteric bacteria (Proteus spp., Klebsiella 
pneumonia, Escherichia coli, and Enterobacteriae) [14]. 
Also, Streptococcus spp. it is commonly associated with 
sinusitis, otitis media, and endocarditis (the latter with 
Grupo S. viridans); a series of recent cases suggest a 
possible increase in the incidence of CA due to group A 
streptococcus [15]. Staphylococcus spp. (mainly aureus 
and epidermidis) infections are related to traumatic brain 
injury, surgery, or skin infections. Neonatal CA may arise 
from Citrobacter or Proteus meningitis, less frequently 
from Escherichia coli and Serratia marcescens [16,17]. 
The data presented are in agreement with the usual 
bacteriological flora observed in otorhinolaryngology and 
infantile meningitis, with Gram-positive cocci in children in 
the context of otorhinolaryngological disease and Gram-
negative bacillus in babies in the context of meningitis 
[18]. 
There are reports in some countries that 
pneumococcal vaccination may contribute in the coming 
years to a variation in the incidence and etiology of CA  
[19,20]. Fungi, parasites, and mycobacteria are 
uncommon pathogens [14]. CA are multiple in most cases
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when the microorganisms are opportunistic. HIV-positive 
children with low CD4 counts are susceptible to the most 
common pathogens, namely Toxoplasma, Nocardia, and 
Mycobacterium spp [21]. Fungal abscesses (mainly 
Aspergillus or Candida) are generally associated with 
recipients of solid organ transplants or children being 
treated for leukemia [22]. 
The etiological diagnosis can be obtained through 
the culture of the abscess pus, acquired by stereotactic 
biopsy or complete aspiration, instead of an excised 
craniotomy [16,19, 23-27]. In some cases, neurosurgery is 
not indicated and therapy should be performed and 
continued empirically, with monitoring of clinical and 
radiological improvement [19,24,28,29]. CAS can result 
from the extension of infection through blood flow from a 
distant focus (dental, sinus, otological, endocarditis, lung or 
skin infections) [30,31]. In newborns, it prevails in cases of 
meningitis or hematogenous dissemination of distant local 
infection [17,32]. 
The patient initially had fever and irritability. Later, 
she developed nausea, vomiting, and seizures. In the 
literature, the most common symptoms of brain abscess are 
fever, disturbance of consciousness, nausea, focal signs, 
and seizures [33]. In infants with ICH, the findings may be 
vomiting, intermittent unconjugated eye movements, 
drowsiness, lethargy, presence of focal neurological signs, 
and the occurrence of seizure [34]. Seizures develop in 
25% of cases and can be the first manifestation of brain 
abscess [35]. 
Corroborating the results described in the present 
study, Sahbudak et al [29] showed in a retrospective 
descriptive study carried out in Turkey with 18 children, 
with a mean age of 48 months with cerebral abscess, 
among them 22% were less than 1 year old, the most 
common symptoms on admission were fever, nausea, and 
vomiting, in addition to 22% having a bulging fontanelle. 
On physical examination, the patient in the study 
revealed a bulging fontanelle, nystagmus, and looking in 
the setting sun, without the occurrence of trauma. In 
addition, during evolution, there was a reduction in abscess 
and the presence of communicating hydrocephalus and 
areas of gliosis. A cerebral abscess can affect the flow of 
CSF through ventricular flow, a function of the 
subarachnoid space, or by cerebral venous compliance 
[36], causing hydrocephalus to appear. Intracranial 
hypertension secondary to cerebral abscess causes 
compensation at the expense of decreasing the volume of 
cerebrospinal fluid and blood since the brain mass is less 
compressible and can cause decreased tissue perfusion and 
worsening cellular damage due to ischemia [34]. 
In 14 days, a brain infection evolves with a 
collection of pus encapsulated in the brain parenchyma and  
 
 
subsequent early cerebritis to the late capsular stage [37].  
Pathogens can spread to the brain through a contiguous 
location (middle ear, mastoid, and paranasal, sinus 
infections) or a discontinuity of the skull (trauma or 
neurosurgery). The location of the CA is related to the 
source of the primary infection. It most often affects the 
frontal lobe (secondary to frontal sinusitis, ethmoid or 
dental infection), followed by parietal and temporal lobes 
(acute otitis media, mastoiditis, or sphenoid sinusitis) and 
less frequently located in the cerebellum and brain stem, 
of otogenic or hematogenic origin [20.27.38]. 
Cerebral abscesses begin with areas of cerebritis 
and progress into discrete collections of encapsulated pus, 
over stages (initial cerebritis, late cerebritis, initial 
capsular, and late capsular) [39], which the imaging 
resources depend on the phase infection [40]. Blood tests 
are the first to be performed in the emergency room to 
assess the presence of altered inflammatory markers due 
to infection (probability of being normal is high) and 
investigation of hematogenous dissemination. They are 
primarily the leukocyte count (if altered, leukocytosis is 
more frequent than leukopenia), C-reactive protein, 
erythrocyte sedimentation rate, and blood cultures [10]. 
In the face of neurological involvement, lumbar 
puncture can be performed for physical-chemical analysis 
of cerebrospinal fluid (CSF) and subsequent culture for a 
specific etiology, even if at low risk [16,20,25,29]. It is 
worth mentioning that the puncture should not be 
performed routinely and is contraindicated in the case of 
non-communicating obstructive hydrocephalus and brain 
dislocation, possible consequences of the mass effect of 
the CA [41]. In cases where it can be performed, the 
count of white blood cells, glucose, and protein content 
can show great variability [20,26]. However, leukocytosis, 
hyperproteinorrhachia, and normal or reduced glucose are 
more frequent [3,18,26]. 
The first type of image performed is CT [5,18,27], 
as it is available in the emergency room and can clarify 
the characteristics of the suspected lesion; then, magnetic 
resonance imaging (MRI) can be performed to confirm the 
diagnosis and improve the characterization of the abscess. 
In the study by Felsenstein et al. [5], all patients whose 
first image was MRI, CA were detected. Thus, MRI is 
suggested as the gold standard image for diagnosis; also 
recommends its use in follow-up. The magnetic resonance 
exam is superior to Computed Tomography for 
investigating CA since it is more sensitive, the contrast of 
less toxicity [39], and the ability to provide an early 
diagnosis to the capsular stage, identifying lesions with 
risk of complications early [42]. However, the age range 
of infants and young children is a limiting factor due to 
the need for long-term sedation for MRI to be performed.
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Empirical antibiotic therapy should be initiated based on the 
likely associated pathogens that depend on the probable 
precipitating source of infection and the results of Gram 
stain. The antibiotic regimen can be modified, if necessary, 
once the results of aspirated pus culture are available [43]. 
The choice of empirical therapy should be based on 
predisposing conditions and, consequently, the 
microorganism that may be involved, should be directed 
towards bactericidal and non-bacteriostatic agents, using 
drugs that can cross the blood-brain barrier (lipophilic, with 
low molecular weight and low connection with plasma 
protein) and safe enough to be administered in high doses 
even for a long time [44-46]. 
Seneviratne Rde (2003) [47] described a study with 
41 patients with brain abscess, in which 30% of the cases 
had congenital heart disease as a predisposing factor, the 
antibiotic used consisted of cefotaxime and metronidazole 
and the result of the treatment was satisfactory. In 2004, 
Jansson described 66 cases of brain abscess initially treated 
with cefotaxime, sixty-two of these patients were 
additionally treated with metronidazole, and surgery was 
also performed on 53 patients, with mortality in this study 
being 12%. Goodkin et al. (2004) [16] reported that in 
cases of abscess <2 cm in diameter, multiple abscesses in 
newborns, antibiotic treatment was used alone, however, 
the mortality rate was 42%. 
Arlotti et al. (2010) [48] provided 
recommendations on the treatment of brain abscesses, 
which can be medicated or surgical. According to these 
recommendations, drug treatment alone can be considered 
in patients without severe neurological symptoms or 
impaired admission (Glasgow scale greater than 12), with 
a small abscess (<2.5 cm) or multiple abscesses, and in 
case of contraindication to surgery; in addition, antibiotics 
represent adjunctive therapy after surgery for large brain 
abscesses or brain abscesses causing a mass effect. 
In pediatric patients, the most common 
combination of intravenous antibiotics is a third-generation 
cephalosporin associated with metronidazole and, in some 
cases, vancomycin [49]. Some studies also report the 
possible use of meropenem alone or in combination with 
other drugs [6,49]. In addition, Krzysztofiak et al. (2017) 
[50] showed the effective use of linezolid in pediatric 
patients, with clinical and radiological evidence of 
improvement. 
Antimicrobial agents must be started intravenously 
and can then be switched to oral therapy, depending on the 
clinic, biochemical and radiological improvement [14]. 
Arlotti et al. (2010) considered a general treatment of 4 to 
6 weeks for patients who underwent surgical treatment and 
enteral therapy for 6-8 weeks for patients treated with only 
drug therapy or with complicated brain abscesses [48]. 
 
 
The appropriate duration of antimicrobial therapy 
for brain abscess remains unclear. A 6 to 8-week course 
of parenteral antibiotics has traditionally been 
recommended, as long as the etiologic organisms are 
susceptible and adequate surgical drainage is achieved 
[51,52]. In selected cases with uncomplicated infection 
and complete surgical remission of a well-designed 
abscess, shorter courses of treatment (3 to 4 weeks) are 
sufficient [52]. However, many studies recommend 2 to 3 
months of additional oral antimicrobial therapy to prevent 
relapse [53]. More complex cases may require a longer 
duration of treatment and rigorous clinical and 
radiographic follow-up. Repeated cranial tomography and 
magnetic resonance imaging will eventually show a 
decrease in the size of the abscess, disappearance of the 
surrounding edema, and less enation of the enhancement 
ring. These improvements are usually seen within 1 to 4 
weeks of management, but complete radiographic 
resolution often extends over several months of follow-up 
[12]. 
In the absence of clinical and radiological 
improvement within 1 to 2 weeks, a neurosurgical 
intervention must be performed [45]. Depending on the 
characteristics, location, and some abscesses, it is 
possible to perform a stereotaxic or endoscopic aspiration 
of the abscess, instead of open surgery (craniotomy with 
excision) [55]. Studies involving mortality rates are more 
frequent in patients with lower scores on the Glasgow 
coma scale, rupture of the intraventricular abscess [5,29] 
congenital immunosuppression, organ transplantation, 
tumors being treated with maternal chemotherapy, 
premature newborns, or malformations [5]. A total 
recovery rate from infection of about 60-70% is reported 
in the case of early diagnosis and adequate therapy [20]. 
However, a smaller percentage of 50% of the cases can 
be explained by the delayed intervention, the presence of 
a greater number of patients with neurological deficiency 
on admission, and severe predisposing conditions [41]. 
Third-generation cephalosporins (ie, cefotaxime, 
ceftriaxone, ceftazidime) are suitable choices for the 
therapy of aerobic gram-negative organisms and provide 
coverage against strep isolates. Ceftazidime adds activity 
against Pseudomonas aeruginosa [12]. Metronidazole also 
penetrates the central nervous system (CNS) very well 
and has good oral absorption capacity. Because of its 
unique activity against anaerobes, metronidazole should 
be used as part of antibiotic therapy [56]. Intracavitary 
administration of antibiotics can be useful only in patients 
with large abscesses, of low resolution, who remain with 
positive culture despite the administration of adequate 
parenteral therapy [57]. 
The intraventricular rupture of a brain abscess re-
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presents a serious complication associated with a mortality 
rate of more than 80%. An aggressive approach that 
includes open craniotomy with debridement of the abscess 
cavity, followed by the placement of a ventriculostomy 
catheter for external drainage and potential intraventricular 
administration [58]. The use of corticosteroids for the 
treatment of brain abscesses is controversial. These agents 
are generally indicated for the control of intracranial 
hypertension and are associated with the risk of herniation 
or significant symptoms such as cerebral edema [12]. 
Severe cerebral edema may require administration of 
intravenous mannitol. Steroids interfere with the 
inflammatory response, delay the encapsulation, increase 
the development of necrosis, potentially reduce the 
concentrations of antibiotics within the purulent collection 
and alter the CT images [59]. 
Anticonvulsants are recommended in children who 
have developed seizures to potentially prevent new 
episodes. The duration of anticonvulsant therapy must be 
individualized and guided by electroencephalographic 
studies (EEG) in the follow-up phase of the disease. Most 
authors recommend at least 3 months of prophylaxis if they 
no longer occur [12]. Clinical sequelae can be found in 
about 30% of patients and are mainly epilepsy, motor, 
visual and auditory deficits, and hydrocephalus [29]. 
Surgically inaccessible lesions, early cerebritis, several small 
abscesses, and significant medical comorbidities are 
indicated treatments with only non-surgical methods. 
Despite the consensus for surgical drainage of the abscess, 
there is no agreement on surgical care for these patients. 
The duration of antibiotic therapy, the choice between oral 
and intravenous routes, the intervals, and the duration of 
these have yet to be debated [60,61]. 
 
Final Considerations 
Pediatric brain abscess is an uncommon disease, 
yet with high morbidity and mortality. In the future, it is 
believed that evaluating changes in the epidemiology of 
brain infections is crucial for prognosis and treatment, 
seeking to take into account, on the one hand, the 
progressive decrease in some predisposing factors, such as 
HIV immunosuppression, congenital heart diseases, on the 
other hand, On the other hand, the decrease in vaccination 
coverage, the increase in resistance to antibiotics, and the 
growing number of patients with iatrogenic 
immunodeficiencies. Prospective multicenter studies are 
needed to achieve more significant evidence, particularly in 
the treatment of brain abscesses. Surgical drainage or 
excision of pediatric abscesses remains the basis of 
treatment both to relieve the mass effect and to provide a 
microbiological diagnosis. The literature demonstrates that  
 
 
broad-spectrum antibiotics and access to CT and MRI 
images decrease the rates of morbidity and mortality. It 
is concluded in the case in question that the follow-up with 
a neurologist should be done throughout life, as it 
presents important neurological sequelae, given the 
complexity that the pathology presents, the therapeutic 
approach involves the administration of broad-spectrum 




Those responsible for the patient in the present 
study have the perspective that the interaction of a 
multidisciplinary medical team will favor the resolution of 
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